kabutan

AFC-HD AMS Life Science Co.,Ltd., 14% Increase in Ordinary Profit, Record High for The First Time in Four Years, Dividend to Rise by 2 yen

Tue Oct 15, 2024 3:00 pm JST Earnings

2927 AFC-HD AMS Life Science Co.,Ltd. 【J-GAAP】

Earnings Report

AFC-HD AMS Life Science Co.,Ltd. <2927> [TSE-S] announced its financial results after the market closed on October 15th (15:00). The consolidated ordinary profit for the fiscal year ending August 2024 increased by 16.3% from the previous period to 1.92 billion yen. For the fiscal year ending August 2025, the profit is expected to grow by 14.3% to 2.2 billion yenExpected to reach record high profits for the first time in four years. This will be the fifth consecutive term of revenue and the third consecutive term of profit growth.

At the same time, the company has decided to increase the dividend this fiscal year to 32 yen, an increase of 2 yen from the previous fiscal year.

In the most recent three-month period, from June to August (4Q), the consolidated ordinary profit decreased to 410 million yen, a 27.9% decrease compared to the same period last year. The operating profit margin drastically worsened from 8.5% in the same period last year to 5.4%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2022 23,024 1,015 1,343 735 52.3 30 Oct 14, 2022 J-GAAP
Aug, 2023 25,579 1,636 1,654 1,102 78.5 27.50 Oct 13, 2023 J-GAAP
Aug, 2024 30,185 1,916 1,921 1,252 89.2 30 Oct 15, 2024 J-GAAP
YoY +18.0% +17.1% +16.1% +13.6% +13.6%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 Guidance 30,234 1,894 1,923 1,154 82.2 30 Sep 17, 2024 J-GAAP
Aug, 2024 Results 30,185 1,916 1,921 1,252 89.2 30 Oct 15, 2024 J-GAAP
Revision Rate -0.2% +1.2% -0.1% +8.5% +8.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep - Feb, 2023 14,542 1,023 1,060 641 45.8 15 Apr 15, 2024 J-GAAP
Sep - Feb, 2024 Guidance 16,400 1,200 1,200 720 51.2 16 Oct 15, 2024 J-GAAP
YoY +12.8% +17.3% +13.2% +12.3% +11.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2023 25,579 1,636 1,654 1,102 78.5 27.50 Oct 13, 2023 J-GAAP
Aug, 2024 30,185 1,916 1,921 1,252 89.2 30 Oct 15, 2024 J-GAAP
Aug, 2025 Guidance 31,100 2,200 2,200 1,320 93.9 32 Oct 15, 2024 J-GAAP
YoY +3.0% +14.8% +14.5% +5.4% +5.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jun - Aug, 2023 6,884 582 569 420 29.9 8.5 Oct 13, 2023 J-GAAP
Sep - Nov, 2023 6,786 478 489 318 22.8 7.0 Jan 12, 2024 J-GAAP
Dec - Feb, 2023 7,756 545 571 323 23.1 7.0 Apr 15, 2024 J-GAAP
Mar - May, 2024 7,802 472 454 281 20.1 6.0 Jul 16, 2024 J-GAAP
Jun - Aug, 2024 7,841 421 407 330 23.5 5.4 Oct 15, 2024 J-GAAP
YoY +13.9% -27.7% -28.5% -21.4% -21.4%

Related Articles